ctrl K

Price Alert

4D Molecular Therapeutics... (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

7.28

0.18 (2.54%)

At close: Aug 15, 2025, 3:59 PM

7.23

-0.62%

After-hours: Aug 15, 2025, 07:58 PM EDT

4D Molecular Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	149.34M	249.11M	218.64M	315.43M
Short-Term Investments	275.54M	39.12M	161.2M	94.78M
Long-Term Investments	80.58M	10.95M	4.91M	67.65M
Other Long-Term Assets	4.26M	684K	1.08M	-58.55M
Receivables	n/a	n/a	n/a	47K
Inventory	n/a	n/a	-5.79M	-8.5M
Other Current Assets	10.05M	8.36M	6.96M	n/a
Total Current Assets	434.93M	296.59M	220.51M	315.43M
Property-Plant & Equipment	40.61M	31.66M	35.35M	28.95M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	125.45M	43.3M	41.34M	38.06M
Total Assets	560.38M	339.89M	261.85M	353.49M
Account Payables	4.39M	3.52M	3.32M	4.76M
Deferred Revenue	257K	273K	884K	2.6M
Short-Term Debt	n/a	n/a	2.65M	1.23M
Other Current Liabilities	n/a	3.87M	1.05M	5.04M
Total Current Liabilities	29.15M	18.95M	15.73M	16.34M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	603K	617K	233K	334K
Total Long-Term Liabilities	20.63M	13.11M	14.78M	18.04M
Total Liabilities	49.78M	32.06M	30.51M	560.48M
Total Debt	24.61M	14.67M	16.12M	16.45M
Common Stock	5K	4K	3K	3K
Retained Earnings	-576.2M	-415.33M	-314.49M	-207M
Comprehensive Income	229K	16K	-1.2M	-423K
Shareholders Equity	510.61M	307.83M	-314.49M	-207M
Total Investments	356.12M	50.08M	166.11M	162.43M